Home
Analyst Insights
Company News
Markets
Top Picks

DiaMedica Therapeutics Inc

DiaMedica Therapeutics Inc (DMAC) EPS is poised to hit -0.17 next quarter: How Investors Can Make It Count the Most?

November 14, 2025

Steve Mayer

DiaMedica Therapeutics Inc (NASDAQ: DMAC) flaunted slowness of -14.10% at $5.42, as the Stock market unbolted on Thursday, before settling ...

Most recent

Company News

TPG Inc (TPG) last month performance of 1.26% certainly makes it a sizzling prospect

Analyst Insights

The key reasons why Fortress Biotech Inc (FBIO) is -40.71% away from 52-week high?

Top Picks

Baidu Inc ADR (BIDU) latest performance of -6.43% is not what was on cards

Markets

Xilio Therapeutics Inc (XLO) recent quarterly performance of -1.06% is not showing the real picture

Company News

Ascendis Pharma A/S ADR (ASND) is 2.26% away from 50-day simple Moving Average despite all headwinds

Analyst Insights

No matter how cynical the overall market is Antero Midstream Corp (AM) performance over the last week is recorded 3.94%

Newsdaemon.com is a business and stock news platform offering in-depth market coverage, aiming to expand readers’ understanding of public and private capital sharing through updates and detailed analysis.

Quick Links

About Us
Contact Us
Disclaimer
Privacy Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Search for:

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled